Key Insights

Highlights

Treatment Research

2 treatments under study, led by The Gmatulip Laryngeal Mask

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • The Gmatulip Laryngeal Mask1
  • The Igel Laryngeal Mask1

Active Sponsors

  • Qilu Hospital of Shandong University1

Top Investigators

Related Conditions

  • General Anesthesia1

Activity Timeline